Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,422Revenue (TTM) $M892Net Margin (%)0.5Altman Z-Score5.7
Enterprise Value $M3,505EPS (TTM) $0.1Operating Margin %0.5Piotroski F-Score6
P/E(ttm)926Beneish M-Score-3.2Pre-tax Margin (%)0.7Higher ROA y-yY
Price/Book4.310-y EBITDA Growth Rate %-4.3Quick Ratio1.5Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %-16.3Current Ratio2.2Lower Leverage y-yY
Price/Free Cash Flow27.6y-y EBITDA Growth Rate %127ROA % (ttm)0.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)0.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M52.8ROIC % (ttm)0.4Gross Margin Increase y-yN

Gurus Latest Trades with HAE

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

HAE is held by these investors:



HAE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KROLL MARK WDirector 2018-01-02Sell7,118$631.49view
GRANADILLO PEDRO PDirector 2017-12-01Sell7,118$57.0612.06view
GELBMAN RONALD GDirector 2017-11-16Sell5,440$56.6912.79view
Burke Willaim PEVP, CFO 2017-11-14Sell13,193$54.0418.32view
Goldstein DanChief Accounting Officer 2017-11-13Sell4,691$54.9316.4view
FOOTE SUSAN BARTLETTDirector 2017-11-10Sell16,926$54.1917.99view
MEELIA RICHARD JDirector 2017-08-10Sell24,086$42.0552.06view
MERRIMAN RONALDDirector 2017-05-22Sell8,196$40.3258.58view
MERRIMAN RONALDDirector 2017-05-22Sell17,471$40.3358.54view
KROLL MARK WDirector 2017-05-15Sell8,580$41.4954.11view

Quarterly/Annual Reports about HAE:

News about HAE:

Articles On GuruFocus.com
Haemonetics to Present at 36th Annual J.P. Morgan Healthcare Conference Dec 22 2017 
Haemonetics Sets Date for Publishing Third Quarter Fiscal 2018 Results: February 6, 2018 Dec 22 2017 
Factors of Influence in 2018, Key Indicators and Opportunity within Endologix, Haemonetics, Prudenti Dec 19 2017 
Haemonetics 2nd Quarter and 1st Half Fiscal 2018 Earnings Release Available on Investor Relations We Nov 07 2017 
Robert E. Abernathy Joins Haemonetics Board of Directors Oct 18 2017 
Haemonetics Sets Date for Publishing 2nd Quarter and 1st Half Fiscal 2018 Results: November 7, 2017 Oct 10 2017 
Haemonetics Appoints David J. Wilson Plasma Business Unit President Sep 14 2017 
Haemonetics to Present at Morgan Stanley's Global Healthcare Conference Aug 29 2017 
Haemonetics 1st Quarter Fiscal 2018 Earnings Release Available on Investor Relations Website Aug 07 2017 
Haemonetics Announces FDA Clearance of New Plasmapheresis System Branded NexSys PCS™ Jul 28 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK